Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
出版年份 2017 全文链接
标题
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
作者
关键词
-
出版物
NUCLEIC ACIDS RESEARCH
Volume 46, Issue 4, Pages 1584-1600
出版商
Oxford University Press (OUP)
发表日期
2017-11-30
DOI
10.1093/nar/gkx1239
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic approaches for spinal muscular atrophy (SMA)
- (2017) M Scoto et al. GENE THERAPY
- Therapies targeting DNA and RNA in Huntington's disease
- (2017) Edward J Wild et al. LANCET NEUROLOGY
- Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate
- (2017) Tracy S. Zimmermann et al. MOLECULAR THERAPY
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- With Alnylam's amyloidosis success, RNAi approval hopes soar
- (2017) Cormac Sheridan NATURE BIOTECHNOLOGY
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
- (2017) Naoki Iwamoto et al. NATURE BIOTECHNOLOGY
- Cellular uptake and trafficking of antisense oligonucleotides
- (2017) Stanley T Crooke et al. NATURE BIOTECHNOLOGY
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
- (2017) David R Corey NATURE NEUROSCIENCE
- Hypertriglyceridaemia and risk of coronary artery disease
- (2017) Željko Reiner Nature Reviews Cardiology
- Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids
- (2017) Nathalie Goemans et al. NEUROMUSCULAR DISORDERS
- The Dilemma of Two Innovative Therapies for Spinal Muscular Atrophy
- (2017) Ans T. van der Ploeg NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
- (2017) K. John Pasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes
- (2017) Michael Tanowitz et al. NUCLEIC ACIDS RESEARCH
- Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
- (2017) Karsten Schmidt et al. NUCLEIC ACIDS RESEARCH
- Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns-an Alternative Viewpoint
- (2017) Adriane N. Irwin et al. PHARMACOTHERAPY
- FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
- (2017) Annemieke Aartsma-Rus Nucleic Acid Therapeutics
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
- (2017) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- Molecular Mechanisms of Antisense Oligonucleotides
- (2017) Stanley T. Crooke Nucleic Acid Therapeutics
- Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
- (2017) Yuanyu Huang Molecular Therapy-Nucleic Acids
- Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells
- (2017) James R. C. Miller et al. Scientific Reports
- Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides
- (2016) Elizabeth J. Ackermann et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- Approving a Problematic Muscular Dystrophy Drug
- (2016) Aaron S. Kesselheim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
- (2016) P. Barton Duell et al. Journal of Clinical Lipidology
- Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?
- (2016) Ying K. Tam et al. JOURNAL OF DRUG TARGETING
- Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
- (2016) Xiaohong Yang et al. JOURNAL OF LIPID RESEARCH
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Alnylam terminates revusiran program, stock plunges
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Visualization of self-delivering hydrophobically modified siRNA cellular internalization
- (2016) Socheata Ly et al. NUCLEIC ACIDS RESEARCH
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis
- (2016) A Tefferi et al. Blood Cancer Journal
- Huntington’s Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
- (2016) Maria Jimenez-Sanchez et al. Cold Spring Harbor Perspectives in Medicine
- Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain
- (2016) Mehran Nikan et al. Molecular Therapy-Nucleic Acids
- Exon skipping therapy for Duchenne muscular dystrophy
- (2015) Ryszard Kole et al. ADVANCED DRUG DELIVERY REVIEWS
- Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma
- (2015) M. H. van der Ree et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oligonucleotide therapeutics: chemistry, delivery and clinical progress
- (2015) Vivek K Sharma et al. Future Medicinal Chemistry
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
- (2015) Anisha A. D'Souza et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
- (2015) Christoph Niemietz et al. MOLECULES
- A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
- (2015) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
- (2015) Gabriela M. Baerlocher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
- (2015) Kim A. Lennox et al. NUCLEIC ACIDS RESEARCH
- The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
- (2015) Timothy A. Vickers et al. NUCLEIC ACIDS RESEARCH
- Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
- (2015) Sebastien A. Burel et al. NUCLEIC ACIDS RESEARCH
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Deciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin Expression
- (2015) Robert Adams et al. PLoS One
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation
- (2015) Aaron J Donner et al. Molecular Therapy-Nucleic Acids
- Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
- (2015) Amy Chan et al. Molecular Therapy-Nucleic Acids
- In VitroAntiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
- (2014) Søren Ottosen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lomitapide and Mipomersen
- (2014) Daniel J. Rader et al. CIRCULATION
- Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways
- (2014) Ivan G. Gomez et al. JOURNAL OF CLINICAL INVESTIGATION
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Therapeutic targeting of microRNAs: current status and future challenges
- (2014) Zhonghan Li et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Aganirsen Antisense Oligonucleotide Eye Drops Inhibit Keratitis-Induced Corneal Neovascularization and Reduce Need for Transplantation
- (2014) Claus Cursiefen et al. OPHTHALMOLOGY
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice
- (2014) M. Yasuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense Oligonucleotide Therapies
- (2014) Kendall S. Frazier TOXICOLOGIC PATHOLOGY
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Liver as a target for oligonucleotide therapeutics
- (2013) Alfica Sehgal et al. JOURNAL OF HEPATOLOGY
- Frontiers and Approaches to Chemical Synthesis of Oligodeoxyribonucleotides
- (2013) Tatyana Abramova MOLECULES
- Argonaute proteins: functional insights and emerging roles
- (2013) Gunter Meister NATURE REVIEWS GENETICS
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells
- (2013) T. Lehto et al. NUCLEIC ACIDS RESEARCH
- Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
- (2013) Luca F. R. Gebert et al. NUCLEIC ACIDS RESEARCH
- Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
- (2012) Dongbo Yu et al. CELL
- Single-Stranded siRNAs Activate RNAi in Animals
- (2012) Walt F. Lima et al. CELL
- Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
- (2012) Glen F. Deleavey et al. CHEMISTRY & BIOLOGY
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Renal uptake and tolerability of a 2′-O-methoxyethyl modified antisense oligonucleotide (ISIS 113715) in monkey
- (2012) Scott P. Henry et al. TOXICOLOGY
- Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
- (2012) Z. Wang et al. Open Biology
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Targeting telomerase-expressing cancer cells
- (2011) Michel M. Ouellette et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Expanding the action of duplex RNAs into the nucleus: redirecting alternative splicing
- (2011) Jing Liu et al. NUCLEIC ACIDS RESEARCH
- Allele-Selective Inhibition of MutantHuntingtinExpression with Antisense Oligonucleotides Targeting the Expanded CAG Repeat
- (2010) Keith T. Gagnon et al. BIOCHEMISTRY
- Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism
- (2010) Jiaxin Hu et al. CHEMISTRY & BIOLOGY
- Off-Target Effects Related to the Phosphorothioate Modification of Nucleic Acids
- (2010) Johannes Winkler et al. ChemMedChem
- Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′O-Methoxyethyl and 2′,4′-Constrained 2′O-Ethyl Nucleic Acid Analogues
- (2010) Punit P. Seth et al. JOURNAL OF ORGANIC CHEMISTRY
- Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
- (2010) Ellen Marie Straarup et al. NUCLEIC ACIDS RESEARCH
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- Telomeres and Telomerase: From Discovery to Clinical Trials
- (2009) David R. Corey CHEMISTRY & BIOLOGY
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
- (2009) Edith L. Pfister et al. CURRENT BIOLOGY
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine
- (2009) Ashley J. Pratt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
- (2009) C. A. Stein et al. NUCLEIC ACIDS RESEARCH
- Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex
- (2008) Yanli Wang et al. NATURE
- Novel Therapeutic Modalities to Address Nondrugable Protein Interaction Targets
- (2008) Errol B De Souza et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now